ArticleCancers2024

Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen-Single-Center Analysis.

Sigrid Machherndl-Spandl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.